{"@id":"https://bioecon.ru/technology/conditionally-active-nanobody-drug-conjugates/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://bioecon.ru/technology/conditionally-active-nanobody-drug-conjugates/","json":"https://bioecon.ru/api/v1/technology/conditionally-active-nanobody-drug-conjugates/index.json"},"id":"conditionally-active-nanobody-drug-conjugates","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/ecowin/","https://bioecon.ru/companies/fermelanta/","https://bioecon.ru/companies/esco-aster/"]},"maturity":7,"name":"Условно-активные конъюгаты нанотел с лекарственными препаратами","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Паннинг pH-чувствительных библиотек"},{"n":2,"title":"Сайт-специфическая конъюгация"},{"n":3,"title":"Валидация проникновения в опухоль"},{"n":4,"title":"Системный клиренс и безопасность"}],"summary":"Однодоменные VHH-нанотела, активирующиеся исключительно в кислой или гипоксической микросреде опухоли и доставляющие цитотоксический пейлоад без поражения здоровых тканей.","url":"/technology/conditionally-active-nanobody-drug-conjugates/","verified":"2026-11-22"}